Ophthalmic company, based in Cheshire to launch new products as it eyes company growth in 2023

By Rich Wilcock

21st Feb 2023 | Healthcare

Spectrum's David Killengrey (image - nub news)
Spectrum's David Killengrey (image - nub news)

Macclesfield-based Spectrum Ophthalmics has set its sights on growth in 2023, as it aims to increase turnover by 15%.

To achieve this, the ophthalmic provider is adding more product ranges to its portfolio and expanding its sales team.

Spectrum Ophthalmics operates nationally and works with the NHS and private sector helping surgeons, optometrists, and ophthalmologists with cutting-edge products, support, and care solutions.

Managing director at Spectrum Ophthalmics, David Killengray, commented: "At some point in our lifetime, most of us will experience impaired vision affecting the day-to-day quality of our lives.

At Spectrum, we are committed to providing eyecare specialists with the absolute best ophthalmic products and solutions that enable them to be more successful and help more patients to enjoy better vision.

Over the next 12 months, we will continue to invest in our product range, unique support solutions, and experienced team to provide ophthalmologists with the confidence to deliver the best eyecare solutions, treatments, advice, and aftercare for their patients."

It is one year since the fast-growing company became part of the Europe-wide healthcare brand Addvision and has launched a range of new products to help this growth, including a dynamic operating chair, premium intraocular lenses, and a range of dry eye solutions aimed at meeting new needs from both b2b and b2c user groups.

Got a business story? email [email protected]

Follow Cheshire Business Nub on FacebookTwitter, and LinkedIn


Related Articles


Alderley Park development looks set to be approved


"You need an incentive to invest" according to AstraZeneca boss

Sign-Up for our FREE Newsletter

We want to provide Congleton with more and more clickbait-free local news.
To do that, we need a loyal newsletter following.
Help us survive and sign up to our FREE weekly newsletter.

Already subscribed? Thank you. Just press X or click here.
We won't pass your details on to anyone else.
By clicking the Subscribe button you agree to our Privacy Policy.